Blog
RSS FeedPosted by Michael Wonder on 24 Feb 2026
PHARMAC proposes to widen access to two medicines for people with melanoma
24 February 2026 - PHARMAC is proposing to widen access to two medicines used to treat melanoma, giving people another ...
Posted by Michael Wonder on 21 Feb 2026
Do children get priority in Australia's drug funding decisions?
20 February 2026 - In Australia, the PBAC recommends which medicines should be subsidised through the PBS. ...
Posted by Michael Wonder on 21 Feb 2026
Canada's public drug plans shouldn't cover new Alzheimer's drug, agency says
19 February 2026 - Lecanemab, also known as Leqembi, is approved to treat mild cognitive impairment, early Alzheimer's. ...
Posted by Michael Wonder on 19 Feb 2026
Clinton's life could be cut short unless he pays thousands for PBS listed medication
18 February 2026 - After being diagnosed with a rare and aggressive form of thyroid cancer 10 years ago, father ...
Posted by Michael Wonder on 18 Feb 2026
PHARMAC proposes funding new treatments that could transform early care for people with chronic lymphocytic leukaemia, a type of blood cancer
18 February 2026 - People in New Zealand living with chronic lymphocytic leukaemia could soon benefit from funded access to ...
Posted by Michael Wonder on 18 Feb 2026
NICE recommends first ever disease modifying treatment for ARG1 deficiency
17 February 2026 - NICE has recommended the first disease modifying treatment for arginase 1 deficiency (ARG1-D), an ultra-rare, inherited and ...
Posted by Michael Wonder on 17 Feb 2026
New iron treatment funded for people who have experienced serious reactions
17 February 2026 - From 1 March 2026, PHARMAC will fund ferric derisomaltose (Monofer) in hospitals for people who have ...
Posted by Michael Wonder on 16 Feb 2026
Cheaper medicines for chronic kidney disease and psoriasis
16 February 2026 - Australians with chronic kidney disease and psoriasis will now have access to cheaper medicines for each ...
Posted by Michael Wonder on 16 Feb 2026
Cheaper medicines for people living with cystic fibrosis
16 February 2026 - The Australian Government is delivering more support for Australians with cystic fibrosis with a new medicine ...
Posted by Michael Wonder on 12 Feb 2026
PHARMAC seeking feedback on plans to modernise the Pharmaceutical Schedule
12 February 2026 - PHARMAC has begun work to update the Pharmaceutical Schedule to make it easier to use, faster ...
Posted by Michael Wonder on 12 Feb 2026
Agenda for the March 2026 PBAC meeting (12 February 2026)
12 February 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version 5). ...
Posted by Michael Wonder on 12 Feb 2026
Lifesaving drugs blocked by Australia’s ‘broken’ approvals process
12 February 2026 - Australia’s processes for funding vital medicines is recognised as broken. Lives are on the line as patients, ...
Posted by Michael Wonder on 12 Feb 2026
Sick Australians risk being locked out of lifesaving medicines by outdated PBS
12 February 2026 - More medicines are successfully treating illness and disease, but Pfizer’s local boss says the PBS is falling ...
Posted by Michael Wonder on 11 Feb 2026
PHARMAC confirms changes to simplify biologic medicine funding criteria
11 February 2026 - PHARMAC has confirmed changes to the Special Authority and Hospital Indication Restrictions criteria for four biologic ...
Posted by Michael Wonder on 11 Feb 2026
Canadians wait, on average, more than 65 weeks longer for access to new medicines than Europeans and 90 weeks more than Americans
10 February 2025 - Canadian patients are waiting, on average, more than 65 weeks longer than Europeans and over 90 ...